SCHEMBL2293253

SCHEMBL2293253

Cc1cccc(C)c1OCc1cc(OC(=O)Cc2ccccc2)c(OC(=O)Cc2ccccc2)cc1C=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.55
L3MBTL1 Q9Y468 3/20 0.42
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PTGER4 P35408 4/20 0.41
PTGER3 P43115 4/20 0.41
PTGER2 P43116 4/20 0.41
PTGER1 P34995 2/20 0.41
KMT2A Q03164 2/20 0.40
PTPN1 P18031 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2292640 0.86 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1ATMTDP1PTGER4
Benzene SCHEMBL2293259 0.85 PTPN1 (0.47) SMN1; SMN2PTGER4PTGER3PTGER2PTGER1
SCHEMBL2292602 0.84 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1ATMTDP1PTGER4
SCHEMBL2290423 0.84 KMT2A (0.39) SMN1; SMN2L3MBTL1TDP1PTGER4PTGER3
SCHEMBL2292761 0.83 PTPN1 (0.48) SMN1; SMN2ATMPTGER4PTGER3PTGER2
SCHEMBL2295286 0.78 ALDH1A1 (0.46) SMN1; SMN2L3MBTL1TDP1KMT2AHTR1A
SCHEMBL2290946 0.75 CDK4 (0.39) SMN1; SMN2KMT2AHTR1AADRA1DADRA1A
SCHEMBL2289128 0.75 ALDH1A1 (0.37) SMN1; SMN2L3MBTL1PTGER4PTGER3PTGER2
SCHEMBL2294671 0.74 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1ATMTDP1PTGER4
SCHEMBL2286452 0.73 ALDH1A1 (0.36) SMN1; SMN2PTGER4PTGER3PTGER2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2149545-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2016-10-05 EP disclosed
US-7994367-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-09 US disclosed
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 US disclosed
EP-2149545-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, C9, TRPA1 SMN1; SMN2 3093/4885L3MBTL1 2751/4885ATM 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.